Minerva Neurosciences (NERV) Tops Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.18), $0.12 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• CareDx completes $171.2M sale of lab products unit to Eurobio Scientific
• After-Hours Stock Movers: NKE, BE, STZ, RIG